Palisade Bio Files 8-K: Other Events
Ticker: PALI · Form: 8-K · Filed: Apr 2, 2026 · CIK: 0001357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $3.0 m, $1.952 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, other-events
Related Tickers: PBLD
TL;DR
PALISADE BIO (PBLD) filed an 8-K for an 'Other Event' on 3/27/26. No details yet.
AI Summary
Palisade Bio, Inc. filed an 8-K on April 2, 2026, reporting other events as of March 27, 2026. The filing does not contain specific financial details or significant business updates beyond the reporting of an event.
Why It Matters
This filing indicates a corporate event occurred for Palisade Bio, Inc. on March 27, 2026, requiring disclosure to the SEC.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting an event without immediate financial implications or significant operational changes disclosed.
Key Players & Entities
- PALISADE BIO, INC. (company) — Filer of the 8-K report
- 0001357459 (company) — CIK number for PALISADE BIO, INC.
- 2026-04-02 (date) — Filing date of the 8-K
- 2026-03-27 (date) — Period of report for the 8-K
FAQ
What specific 'Other Event' is being reported by Palisade Bio, Inc.?
The provided filing details do not specify the nature of the 'Other Event' reported as of March 27, 2026.
When was this 8-K filing accepted by the SEC?
The 8-K filing was accepted by the SEC on April 2, 2026.
What is the CIK number for Palisade Bio, Inc.?
The CIK number for Palisade Bio, Inc. is 0001357459.
What is the business address of Palisade Bio, Inc.?
The business address for Palisade Bio, Inc. is 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009.
What SIC code is associated with Palisade Bio, Inc.?
Palisade Bio, Inc. is associated with SIC code 2836, which pertains to Biological Products (No Diagnostic Substances).
Filing Stats: 737 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2026-04-02 08:34:41
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
- $3.0 m — nvestor") for a total purchase price of $3.0 million, or $1.952 per Share (which repre
- $1.952 — otal purchase price of $3.0 million, or $1.952 per Share (which represents the average
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-26-014822.txt ( ) — 199KB
- pali-20260327.xsd (EX-101.SCH) — 3KB
- pali-20260327_lab.xml (EX-101.LAB) — 33KB
- pali-20260327_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 2, 2026 Palisade Bio, Inc. /s/ J.D. Finley By: J.D. Finley Chief Executive Officer